MedCity News

An older African American man with glasses carefully arranges his daily medications in a blue pill organizer. He sits at a wooden table near a window with blinds, methodically sorting prescription bottles and preparing his medication schedule.

Chronic Overmedication: The Polypharmacy Waste and Safety Problem

In the Absence of Objective Measures for ALS, Caregivers are the Only Witnesses. We Shouldn’t Have To Be.

The way we measure ALS progression is failing patients. We are entering a new era of ALS therapeutics but still relying on the same blunt instruments of measurement.

By Nadia Sethi

MedCity Influencers

Valuing Early-Stage Life Sciences Companies: The Why, the How, and the Impact

Valuing early-stage life sciences companies can be complex. Because product development can take several years and be capital intensive, obtaining an accurate valuation is essential to align management’s, the shareholders’, and current and potential investors’ understanding of estimated value.

By Ron Melling, Tom Shoemaker, and Michael Taglieri

BioPharma, Devices & Diagnostics, Health Tech, Consumer / Employer

Businesswoman using smartwatch in a city.

Verily & Samsung Team Up to Bring Smartwatch Data into Clinical Trials

Verily and Samsung are partnering to integrate data from Galaxy smartwatches into Verily’s Pre platform. The goal is to create an end-to-end system that pharma researchers can use to deploy wearable devices in studies, analyze patient data remotely and then interpret the results.

By Katie Adams

Latest Video

Latest News

Health Tech, Consumer / Employer

Eight Sleep Raises $50M to Build Predictive AI for Sleep

Eight Sleep's $50 million raise was led by Tether Investments. In total, Eight Sleep has raised over $250 million, and this round brings the company’s valuation to $1.5 billion.

By Marissa Plescia

BioPharma, Pharma

Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision

GSK licensed to Alfasigma global rights to linerixibat, a drug developed to treat the rare liver disease primary biliary cholangitis (PBC). The move follows Alfasigma’s 2025 voluntary market withdrawal of Ocaliva, a PBC drug that had sparked safety concerns from U.S. and European regulators.

By Frank Vinluan

MedCity Influencers

HIPAA Was Built for an Analog Era, Healthcare AI Has Outgrown It

Healthcare AI in the U.S. has progressed to a point where traditional, HIPAA-style compliance alone is no longer adequate. The next phase of regulation and market expectation will require continuous, medical-grade AI governance, and companies that don’t adapt now will be left behind.

By Simon Kos

MedCity Influencers

Full length of senior woman holding remote control while helping man with disability in motorized wheelchair to disembar

Dialysis Isn’t Optional. Transportation Can’t Be Either

Every day NEMT makes dialysis possible for thousands of patients. Isn’t it time we view medical transportation not as an afterthought, but as a crucial component of our society’s healthcare?

By Darren Harline

MedCity Influencers

Eyes on the Future: How Retinal Imaging Is Reframing Preventive Medicine

From cardiovascular disease to Alzheimer’s, the retina is proving to be the body’s most revealing health monitor, positioning optometrists at the forefront of early detection and integrated care.

By Dr. Steve Berry

Balancing the Role of Physicians and AI [Video]

At the ViVE conference in LA, Smarter Technologies Chief Medical Officer Ruben Amarasingham MD talked with Katie Adams about the company's larger goals for AI: to improve the accuracy of data and make healthcare less burdensome for physicians and clinicians.

By Smarter Technologies and MedCity News

Modernizing Care: From Automated Workflows to Smarter Medication Management [Video]

Executives from Artera and DrFirst join MedCity News from Vive in LA.

By Stephanie Baum

Policy

It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?

Experts say the bipartisan Break Up Big Medicine Act — aimed at breaking up vertically integrated healthcare companies — faces slim chances of passing despite recent PBM reforms.

By Marissa Plescia

The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]

MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.

By Clever Care Health Plan and MedCity News

Artificial Intelligence, Hospitals, Health Tech

Female medical expert consoling senior patient. Senior man getting test results from doctor. They are sitting in examination room.

Why This Rural Health System Is Scaling AI for Point-of-Care Decision Making

Presbyterian Healthcare Services has rolled out an AI-powered precision care platform to 200 primary care providers, helping them review charts, identify care gaps and make faster treatment decisions. The tool is also designed to maximize each visit, especially for rural patients who travel long distances to receive care.

By Katie Adams

BioPharma, Pharma

Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals, But Can It Compete?

Petrelintide posted Phase 2 results showing tolerability comparable to a placebo, but average weight loss that was less than what analysts expected. The Zealand Pharma drug, in development under a partnership with Roche, is a peptide engineered to activate the amylin receptor.

By Frank Vinluan

MedCity Influencers

Virtual-First Care Shouldn’t Spark an “A-Ha” Moment Anymore

Virtual-first done well - fully integrated with the EHR, aligned with health system clinical and quality governance, capable of warm handoffs, and simple enough that patients don’t need instructions - creates genuine surprise. That surprise is the opportunity and the problem.

By Michael Dalton

MedCity Influencers

For Anthropic, Pragmatism Is the More Trustworthy Position

From Pentagon contracts to patient care, the AI leader's policy shifts matter.

By Deepak Sirdeshmukh

MedCity Influencers

The Moment is Now: Preventive Cardiac Care is in Sight

The combination of AI and advanced signal processing, along with innovations in digital and wearable tech, places us in a moment where providers will soon be able to have high-quality data that presents the opportunity to shift from reactive heart failure treatment to preventive cardiac care.

By Chris Darland

Artificial Intelligence, Devices & Diagnostics, Health Tech, Payers, Providers

CVS, Humana & More Are Turning to Google’s AI Models

Google Cloud is partnering with healthcare organizations including CVS Health, Humana, Highmark Health, Quest Diagnostics and Waystar to deploy agentic AI tools across patient engagement, clinical workflows and revenue cycle management

By Katie Adams

Consumer / Employer, Health Tech

Why Quantum Health Acquired Virtual Care Company CirrusMD

Quantum Health acquired CirrusMD to add 24/7 physician chat to its healthcare navigation services and deliver faster clinical support.

By Marissa Plescia

BioPharma, Pharma

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma

Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in children.

By Frank Vinluan